http://linkedlifedata.com/r... | rdf:type | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | UK | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | Mol.Immunol. | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | MOIMD5 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 0921 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 0161-5890 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 46 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 1750 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 1755 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 10.1016/j.molimm.2009.01.026 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:119250681 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | Structural characterization of a human Fc fragment engineered for extended serum half-life. | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |